NDTDI

NDTDI
Clinical data
Other names	N-(2-Diethylcarbamoylethyl)-N-methyl-4,α-methylenetryptamine; N-(3-Diethylamino-3-oxopropyl)-N-methyl-4,α-methylenetryptamine; 8,10-Seco-LSD
Drug class	Simplified/partial LSD analogue
ATC code	None;
Legal status
Legal status	Illegal in Latvia;
Identifiers
	IUPAC name N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide;
PubChem CID	163192742;
CompTox Dashboard (EPA)	DTXSID601342245 ;
Chemical and physical data
Formula	C19H27N3O
Molar mass	313.445 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)C(=O)CCN(C)C1Cc3cccc2ncc(C1)c23;
	InChI InChI=1S/C19H27N3O/c1-4-22(5-2)18(23)9-10-21(3)16-11-14-7-6-8-17-19(14)15(12-16)13-20-17/h6-8,13,16,20H,4-5,9-12H2,1-3H3; Key:JECGWOMOCPQHDH-UHFFFAOYSA-N;

NDTDI, also known as 8,10-seco-LSD, is a tricyclic tryptamine derivative which is thought to act as a serotonin receptor agonist, though its pharmacology has not been studied in detail.^[1] It is a structurally simplified analogue of the psychedelic drug lysergic acid diethylamide (LSD) and is reported to retain similar effects, though with many times lower potency.^[1] NDTDI is specifically the analogue of LSD in which the carbon atom at position 9 of the ergoline ring system has been removed.^[1] It has been sold as a designer drug since 2016 and was first identified by a forensic laboratory in Slovenia in 2017.^[2] NDTDI was made illegal in Latvia in March 2017.^[3]

Quick Facts Clinical data, Other names ...

The simplified analogue of NDTDI and LSD in which the carbons at positions 9 and 10 of the ergoline ring system have been removed, resulting in a fully non-rigid tryptamine derivative, is N-DEAOP-NMT.^[4]^[5]

[1]

[2]

[3]

[4]

[5]

NDTDI

See also

References

External links

Wikiwand - on